Importantly, dulaglutide showed reduced major adverse cardiovascular events (MACE) in the REWIND trial, making it another GLP-1 RA with proven cardiovascular benefit
As a weight-loss medication, GLP-1 medication works by regulating appetite, reducing food intake, and improving metabolic function
Beyond fat loss, Tesamorelin increases lean body mass by 1.42 kg across randomized clinical trials, improves lipid profiles (reducing triglycerides by 48 mg/dL and total cholesterol by 8 mg/dL at 52 weeks), and lowers hepatic fat fraction by 4.9% at 12 months in patients with NAFLD
For others, the two drugs together may still lean toward Lexapro and Adderall weight loss due to Adderalls stronger appetite suppression
L-Carnitine Directions Follow the directions on the drug label or as provided by your veterinarian